BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11311731)

  • 1. Naloxone blocks 'anxiolytic' effects of neuropeptide Y.
    Britton KT; Southerland S
    Peptides; 2001 Apr; 22(4):607-12. PubMed ID: 11311731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic activity of NPY receptor agonists in the conflict test.
    Britton KT; Southerland S; Van Uden E; Kirby D; Rivier J; Koob G
    Psychopharmacology (Berl); 1997 Jul; 132(1):6-13. PubMed ID: 9272753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
    Britton KT; Akwa Y; Spina MG; Koob GF
    Peptides; 2000 Jan; 21(1):37-44. PubMed ID: 10704717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects.
    Heilig M; McLeod S; Brot M; Heinrichs SC; Menzaghi F; Koob GF; Britton KT
    Neuropsychopharmacology; 1993 Jun; 8(4):357-63. PubMed ID: 8099792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test.
    Heilig M; McLeod S; Koob GK; Britton KT
    Regul Pept; 1992 Sep; 41(1):61-9. PubMed ID: 1360689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze.
    Ferris P; Seward E; Dawson GR
    J Psychopharmacol; 2001 Jun; 15(2):76-82. PubMed ID: 11448091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NPY receptors and opioidergic system are involved in NPY-induced feeding in goldfish.
    de Pedro N; López-Patiño MA; Guijarro AI; Pinillos ML; Delgado MJ; Alonso-Bedate M
    Peptides; 2000 Oct; 21(10):1495-502. PubMed ID: 11068096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahypothalamic discriminative stimulus effects of neuropeptide Y.
    O'Hare E; Cleary J; Weldon DT; Pomonis JD; Billington CJ; Levine AS
    Pharmacol Biochem Behav; 1998 Feb; 59(2):375-8. PubMed ID: 9476984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.
    Schmidt-Mutter C; Pain L; Sandner G; Gobaille S; Maitre M
    Eur J Pharmacol; 1998 Jan; 342(1):21-7. PubMed ID: 9544788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models.
    Heilig M; Söderpalm B; Engel JA; Widerlöv E
    Psychopharmacology (Berl); 1989; 98(4):524-9. PubMed ID: 2570434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrus variation in anxiolytic-like effects of intra-lateral septal infusions of the neuropeptide Y in Wistar rats in two animal models of anxiety-like behavior.
    Molina-Hernández M; Olivera-Lopez JI; Patricia Tellez-Alcántara N; Pérez-García J; Teresa Jaramillo M
    Peptides; 2006 Nov; 27(11):2722-30. PubMed ID: 16806581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding.
    Heilig M
    Regul Pept; 1995 Oct; 59(2):201-5. PubMed ID: 8584755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect.
    Li Y; Li JJ; Yu LC
    Brain Res; 2002 Jun; 940(1-2):69-78. PubMed ID: 12020877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.
    Trent NL; Menard JL
    Pharmacol Biochem Behav; 2011 Oct; 99(4):580-90. PubMed ID: 21693128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of naloxone on neuropeptide Y-induced feeding.
    Rudski JM; Grace M; Kuskowski MA; Billington CJ; Levine AS
    Pharmacol Biochem Behav; 1996 Aug; 54(4):771-7. PubMed ID: 8853202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of norbinaltorphimine, beta-funaltrexamine and naltrindole on NPY-induced feeding.
    Kotz CM; Grace MK; Billington CJ; Levine AS
    Brain Res; 1993 Dec; 631(2):325-8. PubMed ID: 8131061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
    Taksande BG; Kotagale NR; Gawande DY; Bharne AP; Chopde CT; Kokare DM
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):955-63. PubMed ID: 24461723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice.
    Belzung C; Agmo A
    Eur J Pharmacol; 1997 Apr; 323(2-3):133-6. PubMed ID: 9128831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of orexigenic counter-regulation for multiple targeted feeding inhibition.
    Schusdziarra V; Zimmermann JP; Schick RR
    Obes Res; 2004 Apr; 12(4):627-32. PubMed ID: 15090630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y and catecholamine-mediated neuronal transmission in mechanisms of feeding-behaviour induction.
    Borisova EV; Kadar T; Telegdi G
    Biomed Sci; 1991; 2(5):455-9. PubMed ID: 1840833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.